Typical Uses:
Reducing visceral fat 
Enhancing cognitive function and memory
Supporting overall metabolic health
Promoting body composition improvements
 
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), used primarily to treat lipodystrophy by reducing visceral fat. It stimulates the pituitary gland to produce and release endogenous growth hormone, leading to increased levels of IGF-1, which in turn enhances lipolysis and improves metabolic functions. Beyond its use in managing HIV-related conditions, Tesamorelin shows promise in cognitive enhancement and overall metabolic health. This peptide is also being explored for its potential benefits in treating other metabolic disorders and promoting body composition improvements.
 
Benefits:
Increases Endogenous Growth Hormone Production: Enhances natural growth hormone levels.
Reduces Visceral Adiposity: Effective in reducing internal organ fat.
Improves Cognitive Function: Potentially enhances memory and learning.
Supports Metabolic Health: Improves lipid and glucose metabolism.
Enhances Muscle Strength and Performance: Aids in maintaining and increasing muscle mass and strength.
 
Possible Side Effects:
Injection Site Reactions: Redness, pain, or swelling at the injection site.
Edema: Swelling due to fluid retention.
Muscle Pain: Reports of muscle aches or joint pain.
Nausea and Vomiting: Possible gastrointestinal discomfort.
Elevated Blood Sugar Levels: Potential increase in blood glucose levels.